BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr | ₹3.65 Cr |
What is the latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹3.65 Cr |
How is Cash Flow from Financing Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 11.97 | |
| Mar2024 | ₹30 Cr | 18.58 | |
| Mar2023 | ₹26 Cr | Positive | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹3.65 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹126.8 Cr | -3.9% | -18.3% | -67.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹290,828.0 Cr | 11.6% | -2.1% | 1.7% | Stock Analytics | |
| REDINGTON | ₹21,252.5 Cr | -0% | -5.6% | 31.1% | Stock Analytics | |
| MMTC | ₹9,913.5 Cr | 2% | -5.9% | -6.6% | Stock Analytics | |
| HONASA CONSUMER | ₹9,561.0 Cr | 3.6% | -5% | 22.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,942.5 Cr | 4.2% | -10.5% | 25.7% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -3.9% |
-18.3% |
-67.4% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses